These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 532648)

  • 1. [Pharmacology of the adrenergic blocking agent dimethylpiperidino ethyl guanidine (author's transl)].
    Chen WZ; Wang ZM; Ting KS
    Yao Xue Xue Bao; 1979 Aug; 14(8):480-5. PubMed ID: 532648
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of N-[2-(2,6-xylyloxy)ethyl]-guanidine sulphate; an adrenergic neurone blocking agent.
    Barron DI; Natoff IL; Vallance DK
    Br J Pharmacol Chemother; 1965 Oct; 25(2):534-44. PubMed ID: 5866731
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some pharmacological actions of methyl-substituted piperidino ethylguanidines (author's transl)].
    Chen W; Zhai S; Ting K
    Yao Xue Xue Bao; 1979; 14(3):161-6. PubMed ID: 506721
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological properties of a new beta-receptor blocking agent.
    Clark B; Saameli K
    Triangle; 1970; 9(8):300-8. PubMed ID: 4397310
    [No Abstract]   [Full Text] [Related]  

  • 5. [The pharmacologic properties of beta-(indolinyl-l)ethylguanidine sulfate].
    Medvedev BA
    Farmakol Toksikol; 1973; 36(5):530-4. PubMed ID: 4788060
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.
    Alps BJ; Johnson ES; Wilson AB
    Br J Pharmacol; 1970 Sep; 40(1):151P-152P. PubMed ID: 4395083
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the pharmacology of N-(2-guanidinoethyl)-4-methyl-1,2,3,6-tetrahydropyridine, a new antihypertensive-acting compound].
    Kroneberg G; Schlossmann K; Stoepel K
    Arzneimittelforschung; 1967 Feb; 17(2):199-207. PubMed ID: 5631784
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the central vasomotor effects of (-)-N-(1-phenylethyl)guanidine, a new adrenergic neuron blocking agent.
    Bapat SK; Dhawan BN; Srimal RC
    Can J Physiol Pharmacol; 1969 Aug; 47(8):725-9. PubMed ID: 5820115
    [No Abstract]   [Full Text] [Related]  

  • 9. Autonomic blocking properties of Wy 21901.
    Alps BJ; Hill M; Johnson ES; Wilson AB
    Br J Pharmacol; 1970 Sep; 40(1):153P. PubMed ID: 4395084
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies on DL-1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide, a new antitumor agent (author's transl)].
    Yamada K; Koshiura R; Miyamoto K; Sanae F
    Yakugaku Zasshi; 1980 Mar; 100(3):347-54. PubMed ID: 7381688
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 12. On the mechanism of action of an adrenergic blocking guanidine (CG8345-Go).
    Kaul CL; Grewal RS
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):192-204. PubMed ID: 7283548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of protriptyline on peripheral autonomic function.
    Cairncross KD; McCulloch MW; Mitchelson F
    J Pharmacol Exp Ther; 1965 Sep; 149(3):365-72. PubMed ID: 5848047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacodynamic study of an alpha adrenolytic compound: acetoxy-thymoxy-ethyl-dimethylamine. II. Pharmacological study].
    Mercier J; Canellas J; Roquebert J
    Therapie; 1971; 26(4):785-94. PubMed ID: 4399130
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological properties of a series of sympatholytics--guanidine derivatives].
    Spivakova RP
    Farmakol Toksikol; 1971; 34(6):650-3. PubMed ID: 5139778
    [No Abstract]   [Full Text] [Related]  

  • 16. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 17. Guanidine and amidoxime derivatives of some diphenylmethyl and related tricyclic ethers.
    van der Stelt C; Hofman PS; Funcke AB; Nauta WT
    Arzneimittelforschung; 1967 Nov; 17(11):1446-9. PubMed ID: 5632166
    [No Abstract]   [Full Text] [Related]  

  • 18. Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine.
    Schmitt H; Fénard S
    Arzneimittelforschung; 1973 Jan; 23(1):40-5. PubMed ID: 4146793
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effects of a beta-adrenergic blocking agent (INPEA) on systemic and coronary hemodynamics in the dog].
    Feruglio FS; Campus S; Pandolfo G; Dessy P; Gagna C; Uslenghi E
    Boll Soc Ital Biol Sper; 1967 Mar; 43(6):313-5. PubMed ID: 6056650
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the circulatory pharmacology of the new beta-adrenergic agent dobutamine (author's transl)].
    Femmer K; Heer S
    Pharmazie; 1980; 35(9):558-63. PubMed ID: 7433510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.